Dr. James Del Rosso (JDR Dermatology Research, Las Vegas, Nevada, USA, and President-Elect American Acne & Rosacea Society) discusses the efficacy and safety results from the CAMP-1 and CAMP-2 studies, highlighting their role in supporting the recent FDA approval cantharidin solution (0.7%) for treatment of molluscum contagiosum. He also examines who benefits most from the […]

Molluscum contagiosum, a common skin infection caused by a poxvirus (molluscum contagiosum virus), usually resulting in benign, mild skin disease characterized by lesions appearing anywhere on the body. In this interview, Dr. James Del Rosso (JDR Dermatology Research, Las Vegas, Nevada, USA, and President-Elect American Acne & Rosacea Society) shares insights into molluscum contagiosum, and […]

The phase III SUNSHINE and SUNRISE were two identical, multicentre, randomized, placebo-controlled, double-blind phase 3 trials performed in 219 primary sites across 40 countries. With few therapeutic options available for patients with moderate-to-severe hidradenitis suppurativa (HS), Dr Afsaneh Alavi (Mayo Clinic College of Medicine, Rochester, MN, USA) joins touchDERMATOLOGY to discuss the limitations of current […]

Explore some of the key insights from EADV 2023: Prof. Thierry Passeron illuminates pigmentary disorders breakthroughs, Dr Raj Chovatiya unveils atopic dermatitis innovations, Prof. Leonardo Marini sheds light on aesthetic medicine developments, and Prof. Dedee Murrell reveals treatment progress exciting clinical trials and key discoveries in blistering and autoimmune diseases. Filmed in coverage of the EADV Annual Meeting. This content was developed by Touch Medical Media and is not affiliated with the  European Academy of Dermatology & Venereology  (EADV) or the congress.